1. Home
  2. MNSB vs CVRX Comparison

MNSB vs CVRX Comparison

Compare MNSB & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

N/A

Current Price

$21.24

Market Cap

166.4M

Sector

Finance

ML Signal

N/A

Logo CVRx Inc.

CVRX

CVRx Inc.

N/A

Current Price

$7.49

Market Cap

171.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MNSB
CVRX
Founded
2003
2000
Country
United States
United States
Employees
204
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.4M
171.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MNSB
CVRX
Price
$21.24
$7.49
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.20
AVG Volume (30 Days)
61.3K
408.2K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
1.85%
N/A
EPS Growth
N/A
23.02
EPS
N/A
N/A
Revenue
N/A
$56,651,000.00
Revenue This Year
$1.50
$16.78
Revenue Next Year
$3.77
$19.73
P/E Ratio
$12.64
N/A
Revenue Growth
N/A
10.45
52 Week Low
$15.00
$4.37
52 Week High
$23.44
$13.34

Technical Indicators

Market Signals
Indicator
MNSB
CVRX
Relative Strength Index (RSI) 45.77 51.93
Support Level $20.88 $6.61
Resistance Level $22.13 $8.45
Average True Range (ATR) 0.60 0.56
MACD -0.15 0.03
Stochastic Oscillator 37.91 47.14

Price Performance

Historical Comparison
MNSB
CVRX

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: